|
ATF7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.500000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52292999999748E-05 |
| Normal-vs-Stage2 |
1.761170E-01 |
| Normal-vs-Stage3 |
5.340800E-01 |
| Normal-vs-Stage4 |
8.286800E-01 |
| Stage1-vs-Stage2 |
1.456790E-01 |
| Stage1-vs-Stage3 |
2.423300E-03 |
| Stage1-vs-Stage4 |
2.960600E-04 |
| Stage2-vs-Stage3 |
4.197000E-01 |
| Stage2-vs-Stage4 |
1.739750E-01 |
| Stage3-vs-Stage4 |
4.867400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.769300E-04 |
| Normal-vs-AfricanAmerican |
4.869200E-01 |
| Normal-vs-Asian |
2.219000E-01 |
| Caucasian-vs-AfricanAmerican |
8.478100E-03 |
| Caucasian-vs-Asian |
2.884800E-01 |
| AfricanAmerican-vs-Asian |
6.394500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.605720E-02 |
| Normal-vs-Female |
2.316300E-03 |
| Male-vs-Female |
3.145600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.663000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.92800000000149E-05 |
| Normal-vs-Age(61-80Yrs) |
2.011400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.489000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.861400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.446800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.498800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.320200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.949370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.515000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.782800E-03 |
| Normal-vs-Grade 2 |
1.82270999999901E-05 |
| Normal-vs-Grade 3 |
9.569700E-02 |
| Normal-vs-Grade 4 |
1.671580E-01 |
| Grade 1-vs-Grade 2 |
2.334400E-02 |
| Grade 1-vs-Grade 3 |
5.636400E-04 |
| Grade 1-vs-Grade 4 |
1.79341999999583E-05 |
| Grade 2-vs-Grade 3 |
6.924700E-03 |
| Grade 2-vs-Grade 4 |
2.03749999999614E-05 |
| Grade 3-vs-Grade 4 |
1.090220E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.32739979802943E-10 |
| Normal-vs-ccB subtype |
6.711800E-01 |
| ccA subtype-vs-ccB subtype |
5.32799999675149E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.841300E-03 |
| Normal-vs-N1 |
6.491400E-01 |
| N0-vs-N1 |
6.190000E-01 |
|
|
